Abstract
Enhanced Green Fluorescent Protein (EGFP) is the most commonly used live cell reporter despite a number of conflicting reports that it can affect cell physiology. Thus far, the precise mechanism of GFP-associated defects remained unclear. Here we demonstrate that EGFP and EGFP fusion proteins inhibit polyubiquitination, a posttranslational modification that controls a wide variety of cellular processes, like activation of kinase signalling or protein degradation by the proteasome. As a consequence, the NF-kappaB and JNK signalling pathways are less responsive to activation, and the stability of the p53 tumour suppressor is enhanced in cell lines and in vivo. In view of the emerging role of polyubiquitination in the regulation of numerous cellular processes, the use of EGFP as a live cell reporter should be carefully considered.
MeSH Terms
Animals
Cell Line
Genes, Reporter
Green Fluorescent Proteins/chemistry,genetics,metabolism
Humans
JNK Mitogen-Activated Protein Kinases/metabolism
Lysine/chemistry
Mice
Mice, Transgenic
NF-kappa B/metabolism
Oncogene Proteins, Fusion/chemistry,genetics,metabolism
Recombinant Fusion Proteins/chemistry,genetics,metabolism
Recombinant Proteins/chemistry,genetics,metabolism
Signal Transduction
Ubiquitination
Chemicals
API2-MALT1 fusion protein, human
NF-kappa B
Oncogene Proteins, Fusion
Recombinant Fusion Proteins
Recombinant Proteins
enhanced green fluorescent protein
Green Fluorescent Proteins
JNK Mitogen-Activated Protein Kinases
Lysine
Authors & Affiliations
8 authors, click to expand affiliations / ORCID
Baens Mathijs
Applied Human Genomics, Center for Human Genetics, Molecular Genetics-Flanders Interuniversity Institute for Biotechnology (VIB), University of Leuven, Belgium. Mathijs.Baens@Med.KULeuven.be
Noels Heidi
Broeckx Vicky
Hagens Sofie
Fevery Sabine
Billiau An D
Vankelecom Hugo
Marynen Peter
References (28)
28 references, click to expand
-
Transgenic expression of green fluorescence protein can cause dilated cardiomyopathy.
Nat Med. 2000 May;6(5):482-3
PMID: 10802676
-
Hsp70 inhibits lipopolysaccharide-induced NF-kappaB activation by interacting with TRAF6 and inhibiting its ubiquitination.
FEBS Lett. 2006 May 29;580(13):3145-52
PMID: 16697380
-
Identification of paracaspases and metacaspases: two ancient families of caspase-like proteins, one of which plays a key role in MALT lymphoma.
Mol Cell. 2000 Oct;6(4):961-7
PMID: 11090634
-
Distinct molecular mechanism for initiating TRAF6 signalling.
Nature. 2002 Jul 25;418(6896):443-7
PMID: 12140561
-
Tissue-specific induction of p53 targets in vivo.
Cancer Res. 2002 Dec 15;62(24):7316-27
PMID: 12499275
-
Cellular inhibitor of apoptosis 1 and 2 are ubiquitin ligases for the apoptosis inducer Smac/DIABLO.
J Biol Chem. 2003 Mar 21;278(12):10055-60
PMID: 12525502
-
The tumour suppressor CYLD negatively regulates NF-kappaB signalling by deubiquitination.
Nature. 2003 Aug 14;424(6950):801-5
PMID: 12917691
-
Green fluorescent protein selectively induces HSP70-mediated up-regulation of COX-2 expression in endothelial cells.
Blood. 2003 Sep 15;102(6):2115-21
PMID: 12805066
-
Cell damage and reactive oxygen species production induced by fluorescence microscopy: effect on mitosis and guidelines for non-invasive fluorescence microscopy.
Plant J. 2003 Oct;36(2):280-90
PMID: 14535891
-
Differential requirement for Malt1 in T and B cell antigen receptor signaling.
Immunity. 2003 Nov;19(5):749-58
PMID: 14614861
-
Regulation of NF-kappaB-dependent lymphocyte activation and development by paracaspase.
Science. 2003 Nov 28;302(5650):1581-4
PMID: 14576442
-
Ubiquitination and translocation of TRAF2 is required for activation of JNK but not of p38 or NF-kappaB.
EMBO J. 2004 Jan 28;23(2):322-32
PMID: 14713952
-
The TRAF6 ubiquitin ligase and TAK1 kinase mediate IKK activation by BCL10 and MALT1 in T lymphocytes.
Mol Cell. 2004 May 7;14(3):289-301
PMID: 15125833
-
Hsp70 promotes TNF-mediated apoptosis by binding IKK gamma and impairing NF-kappa B survival signaling.
Genes Dev. 2004 Jun 15;18(12):1466-81
PMID: 15198984
-
Signaling to NF-kappaB.
Genes Dev. 2004 Sep 15;18(18):2195-224
PMID: 15371334
-
Neuronal co-expression of EGFP and beta-galactosidase in mice causes neuropathology and premature death.
Neurobiol Dis. 2004 Nov;17(2):310-8
PMID: 15474368
-
A multiubiquitin chain is confined to specific lysine in a targeted short-lived protein.
Science. 1989 Mar 24;243(4898):1576-83
PMID: 2538923
-
The human heat-shock protein family. Expression of a novel heat-inducible HSP70 (HSP70B') and isolation of its cDNA and genomic DNA.
Biochem J. 1990 Apr 1;267(1):125-32
PMID: 2327978
-
Crystal structure of the Aequorea victoria green fluorescent protein.
Science. 1996 Sep 6;273(5280):1392-5
PMID: 8703075
-
Mdm2 promotes the rapid degradation of p53.
Nature. 1997 May 15;387(6630):296-9
PMID: 9153395
-
Regulation of p53 stability by Mdm2.
Nature. 1997 May 15;387(6630):299-303
PMID: 9153396
-
Generating green fluorescent mice by germline transmission of green fluorescent ES cells.
Mech Dev. 1998 Aug;76(1-2):79-90
PMID: 9867352
-
Is green fluorescent protein toxic to the living cells?
Biochem Biophys Res Commun. 1999 Jul 14;260(3):712-7
PMID: 10403831
-
Constitutive NF-kappaB activation by the t(11;18)(q21;q21) product in MALT lymphoma is linked to deregulated ubiquitin ligase activity.
Cancer Cell. 2005 May;7(5):425-31
PMID: 15894263
-
Trim32 is a ubiquitin ligase mutated in limb girdle muscular dystrophy type 2H that binds to skeletal muscle myosin and ubiquitinates actin.
J Mol Biol. 2005 Nov 25;354(2):413-24
PMID: 16243356
-
GFP expression in muscle cells impairs actin-myosin interactions: implications for cell therapy.
Nat Methods. 2006 May;3(5):331
PMID: 16628201
-
Selective expansion of marginal zone B cells in Emicro-API2-MALT1 mice is linked to enhanced IkappaB kinase gamma polyubiquitination.
Cancer Res. 2006 May 15;66(10):5270-7
PMID: 16707452
-
Activation of the IkappaB kinase complex by TRAF6 requires a dimeric ubiquitin-conjugating enzyme complex and a unique polyubiquitin chain.
Cell. 2000 Oct 13;103(2):351-61
PMID: 11057907